MetLife Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-50,524
| Closed | -$9.28M | – | 2601 |
|
|
2021
Q2 | $9.28M | Sell |
50,524
-1,153
| -2% | -$212K | 0.08% | 204 |
|
|
2021
Q1 | $7.9M | Sell |
51,677
-760
| -1% | -$116K | 0.07% | 238 |
|
|
2020
Q4 | $8.19M | Sell |
52,437
-2,410
| -4% | -$377K | 0.08% | 217 |
|
|
2020
Q3 | $6.28M | Sell |
54,847
-2,422
| -4% | -$277K | 0.07% | 257 |
|
|
2020
Q2 | $6.43M | Buy |
57,269
+229
| +0.4% | +$25.7K | 0.07% | 237 |
|
|
2020
Q1 | $5.12M | Sell |
57,040
-1,746
| -3% | -$157K | 0.07% | 242 |
|
|
2019
Q4 | $6.36M | Sell |
58,786
-2,234
| -4% | -$242K | 0.07% | 265 |
|
|
2019
Q3 | $5.98M | Sell |
61,020
-788
| -1% | -$77.2K | 0.07% | 277 |
|
|
2019
Q2 | $8.1M | Sell |
61,808
-1,703
| -3% | -$223K | 0.09% | 207 |
|
|
2019
Q1 | $8.59M | Sell |
63,511
-278
| -0.4% | -$37.6K | 0.09% | 198 |
|
|
2018
Q4 | $6.21M | Sell |
63,789
-1,029
| -2% | -$100K | 0.08% | 231 |
|
|
2018
Q3 | $9.01M | Sell |
64,818
-681
| -1% | -$94.7K | 0.09% | 195 |
|
|
2018
Q2 | $8.13M | Sell |
65,499
-1,213
| -2% | -$151K | 0.1% | 183 |
|
|
2018
Q1 | $7.44M | Sell |
66,712
-2,413
| -3% | -$269K | 0.09% | 208 |
|
|
2017
Q4 | $8.27M | Buy |
+69,125
| New | +$8.27M | 0.09% | 193 |
|